
    
      A multi-center, randomised, double-blind, parallel-group phase III study to assess high dose
      esomeprazole Na i.v. treatment (bolus infusion of 80 mg followed by a continuous infusion of
      8 mg per hour administered for 72 hours) for prevention of rebleeding
    
  